The development of Vireodt's method for simultaneous estimation of ranitidine and domperidone involves absorbance measurement at 326 nm and 287 nm corresponding to the respective absorption maxima. Both the drugs obey Beer Lambert's law in the range of 3.0-50 µg/ml for ranitidine and 0.2-3.5 µg/ml for domperidone. The tablet formulation (Random, Mankind) was evaluated for the percent content of both the drugs at the selected wavelengths. The method developed was validated to determine its accuracy, precision, specificity and ruggedness. The recovery study was carried out by standard addition method. The average percent recovery was found to be 99.65±0.47 for ranitidine and 100.06±0.18 for domperidone.
Ranitidine is white pale yellow crystalline powder, mg/ml of RAN and DOM (standard solution). Both the sensitive to light and moisture. Chemically it is 1,1-drugs were scanned in the scanning range of 200-400 nm.
ethenediamine-N-[2[[[5(dimethylamino)methyl]-2-
The scanned spectra were then analyzed for the furanyl]methyl] thio]ethyl]-N'-methyl-2-nitro monohydrochloride.
selection of wavelengths (λ max It is used as H 2-receptor antagonist and is also used in Dilutions were made to standard solutions of RAN and the management of ulceration. It is official in IP 1 and DOM individually, and mixture of RAN and DOM was USP 2 . Domperidone is a white, or almost white, powder; scanned for the linearity curve response on the selected chemically it is 5-chloro
benzimidazole-2-one. It is used as dopamine antagonist Accurately weighed quantity of RAN equivalent to 45 mg and antiemetic drug. It is official in BP 3 .
was dissolved in methanol and volume was made up to 50 ml (stock solution C). Accurately weighed quantity of Literature survey revealed that there are many methods DOM equivalent to 50 mg was dissolved in 50 ml like HPLC 4, 5 , UV 6, 7 -spectrophotometric HPTLC 8, 9 , NMR 10 volumetric flask and volume was made up to mark with for individual determination of ranitidine and methanol. From this, 3.0 ml of solution was taken in 100 domperidone. The only method reported for simultaneous ml volumetric flask and volume was made up by methanol estimation of ranitidine and domperidone in their (standard solution D). From the stock solution C, 10.0 ml combined dosage form is by HPLC 11 . An attempt was was taken in 100 ml volumetric flask; and from solution D, made to develop accurate, precise, reproducible and 10 ml was taken in the same volumetric flask, mixed and ) for both the drugs. volume was adjusted to 100.0 ml with distilled water. The absorbance of the resultant solution was measured at 326 nm and 287 nm. Twenty film-coated tablets (Labelled by Random to contain RAN 150 mg and DOM 10 mg per tablet) were weighed and finely powdered. An accurately weighed quantity of tablet powder equivalent to 45 mg of RAN (i.e., 3.0 mg of DOM) was transferred to a 50 ml volumetric flask, dissolved and volume was adjusted with methanol. The solution was then filtered through grade I filter paper. From this filtrate, 5.0 ml was further diluted to 50 ml mark with distilled water to get the final concentration of 45 µg/ml of RAN and 3 µg/ml of DOM. The absorbance of the resultant solution was measured at 326 nm and 287 nm. www.ijpsonline.com
The accuracy of the proposed method was ascertained by carrying out recovery studies by standard addition method. The recovery study was performed to determine if there was any positive or negative interference from excipients present in formulation. The method was ascertained on the basis of recovery study by standard addition method applied to reanalyzed sample. Precision of an analytical method is expressed as SD or RSD of a series of measurements. It was ascertained by replicate estimation of drug by the proposed method. The specificity is the ability to assess unequivocally the ±SD was found to be '99.91±0.27 and 99.88±0.38' and '99.75±0.78 and 99.81±0.0.57' for ranitidine and domperidone respectively. The method was validated according to ICH guidelines. The accuracy of the method was evaluated by percentage recovery (by standard addition method) of both the drugs. The average percent recovery was found to be 99.65±0.47 and 100.06±0.18. The result of the method lies within the prescribed limit of 98-102%, showing that the method is free from interference from excipients. The next parameter considered was precision. The replicate analyte for the presence of interesting components that estimation of both RAN and DOM in the same batch of may be expected to be present, such as impurities, tablets was analyzed by the proposed method and has degradation product and matrix components. The sample yielded quite concurrent results, indicating reliability of solution was prepared to get a mixed standard solution the method. The values of SD or RSD and coefficient of and allowed to be stored for 24 h under the following correlation are within the prescribed limit of 2%, showing different conditions, like room temperature (normal), at high precision of the method. 50º after addition of 1.0 ml of 0.1 N of hydrochloric acid (acid), at 50º after addition of 1.0 ml of 0.1 N of sodium Other parameters studied were specificity and ruggedness hydroxide (alkali), at 50° after addition of 3% of hydrogen to study degradation and stability of the method. In peroxide (oxidation), at 60° (heat), in UV-cabinet at 265 nm specificity study, the sample was exposed to different stress (UV). After 24 h, the contents of the flask were made to conditions like acid, alkali, oxide, heat and UV/visible light, undergo the same treatment as previously described.
showing degradation of the drugs under oxide and acidic Test for ruggedness was carried out under different conditions, but this method is incapable of finding exact conditions, i.e., different days and by different analysts.
degradation of drugs. The last parameter studied was ruggedness, which shows that the result of estimation for An attempt was made to develop a fast, sensitive, precise, the proposed method was reproducible under different reproducible and economical analytical method for conditions, like different days and by different analysts, as simultaneous estimation of RAN and DOM in their shown in Table 1 . The above-evaluated parameters in the combined dosage form. DOM was standardized by official proposed method revealed that the experimental study method reported in British Pharmacopoeia, and the purity signifies simple, accurate, fast, precise and reproducible of the sample was found to be 99.80%. The purity of Vireodt's method for simultaneous estimation of RAN and RAN was considered as provided by M/s Cadila DOM in their combined dosage form and can be used for Pharmaceuticals Ltd., viz., 99.92%. The diluted solution routine analysis of both the drugs in commercially available was scanned to obtain spectrum for both RAN and DOM. marketed formulations. of both the drugs were determined from the obtained spectra -326 nm for RAN and 287 nm for a d f r o m s www.ijpsonline.com Nagpur University, Nagpur, for providing laboratory facilities. Authors are also thankful to M/s Cadila Pharma Ltd., Ahmedabad; and M/s Ipca Laboratories Ltd., Mumbai, for providing gift samples of ranitidine and domperidone.
